182 related articles for article (PubMed ID: 33483844)
21. The risk of thyroid cancer and obesity: A nationwide population-based study using the Korea National Health Insurance Corporation cohort database.
Son H; Lee H; Kang K; Lee I
Surg Oncol; 2018 Jun; 27(2):166-171. PubMed ID: 29937167
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.
Chuang SC; Hashibe M; Yu GP; Le AD; Cao W; Hurwitz EL; Rao JY; Neugut AI; Zhang ZF
Cancer Lett; 2006 Jul; 238(1):42-52. PubMed ID: 16039041
[TBL] [Abstract][Full Text] [Related]
23. Markedly increased risk of malignancies in women with endometriosis.
Eoh KJ; Han M; Kim EH; Jung I; Kim YT
Gynecol Oncol; 2021 Apr; 161(1):291-296. PubMed ID: 33514482
[TBL] [Abstract][Full Text] [Related]
24. Radiation and Second Primary Thyroid Cancer Following Index Head and Neck Cancer.
Polednik KM; Simpson MC; Adjei Boakye E; Mohammed KA; J Dombrowski J; Varvares MA; Osazuwa-Peters N
Laryngoscope; 2019 Apr; 129(4):1014-1020. PubMed ID: 30208210
[TBL] [Abstract][Full Text] [Related]
25. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
Sohn SY; Choi JH; Kim NK; Joung JY; Cho YY; Park SM; Kim TH; Jin SM; Bae JC; Lee SY; Chung JH; Kim SW
Thyroid; 2014 May; 24(5):872-7. PubMed ID: 24295076
[TBL] [Abstract][Full Text] [Related]
26. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
[TBL] [Abstract][Full Text] [Related]
27. J-Shaped Association Between Postoperative Levothyroxine Dosage and Fracture Risk in Thyroid Cancer Patients: A Retrospective Cohort Study.
Shin DW; Suh B; Lim H; Yun JM; Song SO; Park Y
J Bone Miner Res; 2018 Jun; 33(6):1037-1043. PubMed ID: 29447437
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for second primary malignancies following thyroid cancer: a nationwide cohort study.
Kim M; Kim H; Park S; Joo J; Kim IJ; Kim BH
Eur J Endocrinol; 2022 Apr; 186(5):561-571. PubMed ID: 35286279
[TBL] [Abstract][Full Text] [Related]
29. Actual causes of death in thyroid cancer patients in Korea: A Nationwide Case Control Cohort Study.
Kim KJ; Jang S; Kim KJ; An JH; Kim NH; Shin DY; Yoo HJ; Kim HY; Seo JA; Kim NH; Lee J; Choi KM; Baik SH; Kim SG
Eur J Endocrinol; 2020 Jan; 182(1):103-110. PubMed ID: 31721722
[TBL] [Abstract][Full Text] [Related]
30. What is the relationship between the local population change and cancer incidence in patients with dyslipidemia: Evidence of the impact of local extinction in Korea.
Jeong W; Choi DW; Kim W; Han KT
Cancer Med; 2024 Apr; 13(7):e7169. PubMed ID: 38597133
[TBL] [Abstract][Full Text] [Related]
31. Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?
Cappagli V; Caldarella A; Manneschi G; Piaggi P; Bottici V; Agate L; Molinaro E; Bianchi F; Elisei R
Int J Cancer; 2020 Nov; 147(10):2838-2846. PubMed ID: 32449158
[TBL] [Abstract][Full Text] [Related]
32. Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma.
Huang J; Walker R; Groome PG; Shelley W; Mackillop WJ
Cancer; 2001 Sep; 92(6):1411-8. PubMed ID: 11745217
[TBL] [Abstract][Full Text] [Related]
33. Risk Factors for Thyroid Cancer: A Hospital-Based Case-Control Study in Korean Adults.
Myung SK; Lee CW; Lee J; Kim J; Kim HS
Cancer Res Treat; 2017 Jan; 49(1):70-78. PubMed ID: 27338034
[TBL] [Abstract][Full Text] [Related]
34. Risk of second primary malignancies in women with papillary thyroid cancer.
Canchola AJ; Horn-Ross PL; Purdie DM
Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
[TBL] [Abstract][Full Text] [Related]
35. Exposure to radiotherapy for first primary cancer as a risk factor for second primary thyroid cancer: A case-control study.
Cuellar Cuellar AA; Cuellar Rivera DI; Fierro-Maya LF; Posso Valencia H
Ann Endocrinol (Paris); 2020 Dec; 81(6):539-544. PubMed ID: 33290749
[TBL] [Abstract][Full Text] [Related]
36. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
Sawka AM; Thabane L; Parlea L; Ibrahim-Zada I; Tsang RW; Brierley JD; Straus S; Ezzat S; Goldstein DP
Thyroid; 2009 May; 19(5):451-7. PubMed ID: 19281429
[TBL] [Abstract][Full Text] [Related]
37. Risk of non-Hodgkin's lymphoma and thyroid cancer in primary Sjögren's syndrome measured using the Korean Health Insurance Claims Database.
Ahn JK; Hwang J; Seo GH
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):40-46. PubMed ID: 31969226
[TBL] [Abstract][Full Text] [Related]
38. (131)I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study.
Ko KY; Kao CH; Lin CL; Huang WS; Yen RF
Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1172-8. PubMed ID: 25900274
[TBL] [Abstract][Full Text] [Related]
39. Thyroid adenomas after solid cancer in childhood.
Haddy N; El-Fayech C; Guibout C; Adjadj E; Thomas-Teinturier C; Oberlin O; Veres C; Pacquement H; Jackson A; Munzer M; N'Guyen TD; Bondiau PY; Berchery D; Laprie A; Bridier A; Lefkopoulos D; Schlumberger M; Rubino C; Diallo I; de Vathaire F
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e209-15. PubMed ID: 22672756
[TBL] [Abstract][Full Text] [Related]
40. Incidence and death rate of sarcoidosis in Korea in association with metabolic diseases.
Choi JY; Lee JH; Seo JM; Yun SY; Koo HYR; Yu DS; Lee YB
J Dermatol; 2022 May; 49(5):488-495. PubMed ID: 35040161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
